Recombinant Rat Apcs protein, His-tagged
Cat.No. : | Apcs-7095R |
Product Overview : | Recombinant Rat Apcs aa. (Thr22~Met222 (Accession # P23680)) fused with N-terminal His tag was produced in E. coli cells. |
- Specification
- Gene Information
- Related Products
Description : | A component of amyloid P. |
Source : | E. coli |
Species : | Rat |
Tag : | His |
Form : | Freeze-dried powder |
Molecular Mass : | Predicted Molecular Mass: 24.3kDa |
Protein length : | Thr22~Met222 (Accession # P23680) |
Endotoxin : | <1.0EU per 1ug (determined by the LAL method) |
Purity : | >95% |
Characteristic : | The isoelectric point is 6.4. |
Applications : | SDS-PAGE; WB; ELISA; IP. |
Stability : | The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition. |
Storage : | Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months. |
Storage buffer : | Supplied as lyophilized form in 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, and preservative |
Reconstitution : | Reconstitute in ddH2O. |
Gene Name : | Apcs amyloid P component, serum [ Rattus norvegicus (Norway rat) ] |
Official Symbol : | Apcs |
Synonyms : | Apcs; amyloid P component, serum; Sap; serum amyloid P-component |
Gene ID : | 29339 |
mRNA Refseq : | NM_017170.2 |
Protein Refseq : | NP_058866.2 |
UniProt ID : | P23680 |
Products Types
◆ Recombinant Protein | ||
Apcs-1261M | Recombinant Mouse Apcs Protein, His-tagged | +Inquiry |
APCS-811H | Recombinant Human APCS Protein | +Inquiry |
Apcs-1658M | Recombinant Mouse Apcs Protein, Myc/DDK-tagged | +Inquiry |
APCS-353H | Recombinant Human APCS Protein, His (Fc)-Avi-tagged | +Inquiry |
APCS-341H | Recombinant Human APCS Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
◆ Native Protein | ||
APCS-8258H | Native Human Serum Amyloid P | +Inquiry |
APCS-31189TH | Native Human APCS | +Inquiry |
◆ Lysates | ||
APCS-1269HCL | Recombinant Human APCS cell lysate | +Inquiry |
APCS-1761RCL | Recombinant Rat APCS cell lysate | +Inquiry |
APCS-3089MCL | Recombinant Mouse APCS cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (20)
Ask a questionThe duration of use of therapy depends on the type of disease and treatment regimen, and needs to be carried out under the guidance of a professional physician.
The advantages and disadvantages of s versus other treatments need to be evaluated in the context of the specific disease and treatment regimen.
The specificity and specificity of s allow them to be used in precision medicine to achieve personalized treatment.
The stability of the is one of the important factors for its clinical application, and poor stability of the protein may lead to adverse reactions in patients or reduce the therapeutic effect.
Recombinant proteins, as exogenous proteins, may cause a response from the immune system, but there are already several techniques used to reduce their immunogenicity.
Recombinant proteins can be used in vaccine preparation, and there are already several vaccines based on s on the market.
The efficacy of s and traditional drugs depends on the type of disease and individual differences, and needs to be selected on a case-by-case basis.
Recombinant proteins can be used to treat a variety of diseases, such as immune deficiency diseases, tumors, cardiovascular diseases, etc.
Recombinant proteins usually need to be administered intravenously, but there are also some oral s that are currently being studied.
With the advancement of technology, the preparation of s has also been continuously improved, and large-scale production has become possible.
Any medical technology and drug treatment has a certain risk, is no exception, need to be reasonable application under the guidance of professional doctors.
The preparation of s is subject to compliance with relevant policies and regulations, particularly with regard to biosafety.
Recombinant protein therapy should follow the basic principles of individuality, pertinence, safety and effectiveness.
The pharmacokinetics and pharmacodynamics of s have been clearly understood, but they still need to be explored and perfected in clinical practice.
The production cost of is relatively high, but because of its therapeutic effect and broad application prospects, it has become an important field in the pharmaceutical industry.
The application of s needs to be adjusted individually according to the specific situation of the patient in order to achieve the optimal therapeutic effect.
Recombinant proteins have been used in the treatment of various neurological diseases, such as multiple sclerosis and Parkinson's disease.
As a new drug therapy technology, has broad application prospects, and more s may be used in the future.
Recombinant proteins are subject to various metabolic and decomposition influences in the body, and different proteins will have different stability and half-lives.
Clinical trials of s are subject to strict compliance with relevant ethical and regulatory requirements and are subject to regulatory approval and supervision.
Customer Reviews (4)
Write a reviewShort half-life and high clearance.
APCS produced by them has low preparation cost and high cost performance.
Stability of APCS is very good, and it can maintain stable performance even in extreme environments, which shows its excellent adaptability and reliability.
Production process is very much in line with the principle of green production.
Ask a Question for All Apcs Products
Required fields are marked with *
My Review for All Apcs Products
Required fields are marked with *
Inquiry Basket